vs
Tarsus Pharmaceuticals, Inc.(TARS)与VERRA MOBILITY Corp(VRRM)财务数据对比。点击上方公司名可切换其他公司
VERRA MOBILITY Corp的季度营收约是Tarsus Pharmaceuticals, Inc.的1.5倍($223.6M vs $151.7M),VERRA MOBILITY Corp净利率更高(12.0% vs -5.5%,领先17.5%),Tarsus Pharmaceuticals, Inc.同比增速更快(128.4% vs 0.1%),Tarsus Pharmaceuticals, Inc.自由现金流更多($13.0M vs $9.6M),过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高(134.4% vs 0.3%)
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司,专注于眼科、皮肤科等专科领域创新疗法的研发和商业化,主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症,核心市场为美国。
Verra Mobility Corp是全球领先的智慧出行技术解决方案提供商,业务涵盖收费管理、停车与交通合规执法、车联网服务及车队管理工具,服务对象包括政府交通部门、租车运营商、商业车队所有者及汽车行业合作伙伴,覆盖北美、欧洲及亚太市场。
TARS vs VRRM — 直观对比
营收规模更大
VRRM
是对方的1.5倍
$151.7M
营收增速更快
TARS
高出128.2%
0.1%
净利率更高
VRRM
高出17.5%
-5.5%
自由现金流更多
TARS
多$3.3M
$9.6M
两年增速更快
TARS
近两年复合增速
0.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $151.7M | $223.6M |
| 净利润 | $-8.4M | $26.7M |
| 毛利率 | — | — |
| 营业利润率 | -5.3% | 23.2% |
| 净利率 | -5.5% | 12.0% |
| 营收同比 | 128.4% | 0.1% |
| 净利润同比 | 63.8% | -17.3% |
| 每股收益(稀释后) | $-0.17 | $0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
TARS
VRRM
| Q1 26 | — | $223.6M | ||
| Q4 25 | $151.7M | $257.9M | ||
| Q3 25 | $118.7M | $261.9M | ||
| Q2 25 | $102.7M | $236.0M | ||
| Q1 25 | $78.3M | $223.3M | ||
| Q4 24 | $66.4M | $221.5M | ||
| Q3 24 | $48.1M | $225.6M | ||
| Q2 24 | $40.8M | $222.4M |
净利润
TARS
VRRM
| Q1 26 | — | $26.7M | ||
| Q4 25 | $-8.4M | $18.9M | ||
| Q3 25 | $-12.6M | $46.8M | ||
| Q2 25 | $-20.3M | $38.6M | ||
| Q1 25 | $-25.1M | $32.3M | ||
| Q4 24 | $-23.1M | $-66.7M | ||
| Q3 24 | $-23.4M | $34.7M | ||
| Q2 24 | $-33.3M | $34.2M |
营业利润率
TARS
VRRM
| Q1 26 | — | 23.2% | ||
| Q4 25 | -5.3% | 16.7% | ||
| Q3 25 | -12.2% | 28.6% | ||
| Q2 25 | -21.6% | 26.8% | ||
| Q1 25 | -33.5% | 25.7% | ||
| Q4 24 | -36.8% | -19.6% | ||
| Q3 24 | -52.3% | 28.3% | ||
| Q2 24 | -81.6% | 27.5% |
净利率
TARS
VRRM
| Q1 26 | — | 12.0% | ||
| Q4 25 | -5.5% | 7.3% | ||
| Q3 25 | -10.6% | 17.9% | ||
| Q2 25 | -19.8% | 16.3% | ||
| Q1 25 | -32.1% | 14.5% | ||
| Q4 24 | -34.8% | -30.1% | ||
| Q3 24 | -48.7% | 15.4% | ||
| Q2 24 | -81.6% | 15.4% |
每股收益(稀释后)
TARS
VRRM
| Q1 26 | — | $0.17 | ||
| Q4 25 | $-0.17 | $0.12 | ||
| Q3 25 | $-0.30 | $0.29 | ||
| Q2 25 | $-0.48 | $0.24 | ||
| Q1 25 | $-0.64 | $0.20 | ||
| Q4 24 | $-0.57 | $-0.39 | ||
| Q3 24 | $-0.61 | $0.21 | ||
| Q2 24 | $-0.88 | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $417.3M | $46.9M |
| 总债务越低越好 | $72.4M | $34.1M |
| 股东权益账面价值 | $343.4M | $272.0M |
| 总资产 | $562.2M | $1.7B |
| 负债/权益比越低杠杆越低 | 0.21× | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
TARS
VRRM
| Q1 26 | — | $46.9M | ||
| Q4 25 | $417.3M | $65.3M | ||
| Q3 25 | $401.8M | $196.1M | ||
| Q2 25 | $381.1M | $147.7M | ||
| Q1 25 | $407.9M | $108.5M | ||
| Q4 24 | $291.4M | $77.6M | ||
| Q3 24 | $317.0M | $206.1M | ||
| Q2 24 | $323.6M | $122.0M |
总债务
TARS
VRRM
| Q1 26 | — | $34.1M | ||
| Q4 25 | $72.4M | $1.0B | ||
| Q3 25 | $72.3M | $1.0B | ||
| Q2 25 | $72.1M | $1.0B | ||
| Q1 25 | $72.0M | $1.0B | ||
| Q4 24 | $71.8M | $1.0B | ||
| Q3 24 | $71.7M | $1.0B | ||
| Q2 24 | $71.6M | $1.0B |
股东权益
TARS
VRRM
| Q1 26 | — | $272.0M | ||
| Q4 25 | $343.4M | $293.0M | ||
| Q3 25 | $335.1M | $403.1M | ||
| Q2 25 | $332.6M | $352.1M | ||
| Q1 25 | $342.5M | $299.6M | ||
| Q4 24 | $224.5M | $265.1M | ||
| Q3 24 | $237.5M | $486.5M | ||
| Q2 24 | $252.2M | $438.6M |
总资产
TARS
VRRM
| Q1 26 | — | $1.7B | ||
| Q4 25 | $562.2M | $1.6B | ||
| Q3 25 | $534.6M | $1.8B | ||
| Q2 25 | $495.0M | $1.7B | ||
| Q1 25 | $500.8M | $1.6B | ||
| Q4 24 | $377.0M | $1.6B | ||
| Q3 24 | $376.3M | $1.9B | ||
| Q2 24 | $376.8M | $1.8B |
负债/权益比
TARS
VRRM
| Q1 26 | — | 0.13× | ||
| Q4 25 | 0.21× | 3.51× | ||
| Q3 25 | 0.22× | 2.55× | ||
| Q2 25 | 0.22× | 2.93× | ||
| Q1 25 | 0.21× | 3.45× | ||
| Q4 24 | 0.32× | 3.90× | ||
| Q3 24 | 0.30× | 2.13× | ||
| Q2 24 | 0.28× | 2.36× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $19.3M | $40.8M |
| 自由现金流经营现金流 - 资本支出 | $13.0M | $9.6M |
| 自由现金流率自由现金流/营收 | 8.6% | 4.3% |
| 资本支出强度资本支出/营收 | 4.2% | — |
| 现金转化率经营现金流/净利润 | — | 1.53× |
| 过去12个月自由现金流最近4个季度 | $-22.3M | $104.6M |
8季度趋势,按日历期对齐
经营现金流
TARS
VRRM
| Q1 26 | — | $40.8M | ||
| Q4 25 | $19.3M | $40.0M | ||
| Q3 25 | $18.3M | $77.7M | ||
| Q2 25 | $-29.4M | $75.1M | ||
| Q1 25 | $-20.7M | $63.0M | ||
| Q4 24 | $-22.2M | $40.5M | ||
| Q3 24 | $-8.7M | $108.8M | ||
| Q2 24 | $-14.4M | $40.0M |
自由现金流
TARS
VRRM
| Q1 26 | — | $9.6M | ||
| Q4 25 | $13.0M | $5.7M | ||
| Q3 25 | $16.3M | $49.0M | ||
| Q2 25 | $-30.4M | $40.3M | ||
| Q1 25 | $-21.2M | $41.7M | ||
| Q4 24 | $-22.3M | $21.6M | ||
| Q3 24 | $-8.9M | $85.1M | ||
| Q2 24 | $-15.4M | $26.0M |
自由现金流率
TARS
VRRM
| Q1 26 | — | 4.3% | ||
| Q4 25 | 8.6% | 2.2% | ||
| Q3 25 | 13.8% | 18.7% | ||
| Q2 25 | -29.6% | 17.1% | ||
| Q1 25 | -27.1% | 18.7% | ||
| Q4 24 | -33.5% | 9.8% | ||
| Q3 24 | -18.6% | 37.7% | ||
| Q2 24 | -37.8% | 11.7% |
资本支出强度
TARS
VRRM
| Q1 26 | — | — | ||
| Q4 25 | 4.2% | 13.3% | ||
| Q3 25 | 1.6% | 11.0% | ||
| Q2 25 | 1.0% | 14.8% | ||
| Q1 25 | 0.8% | 9.5% | ||
| Q4 24 | 0.1% | 8.5% | ||
| Q3 24 | 0.6% | 10.5% | ||
| Q2 24 | 2.5% | 6.3% |
现金转化率
TARS
VRRM
| Q1 26 | — | 1.53× | ||
| Q4 25 | — | 2.12× | ||
| Q3 25 | — | 1.66× | ||
| Q2 25 | — | 1.95× | ||
| Q1 25 | — | 1.95× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.13× | ||
| Q2 24 | — | 1.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
TARS
暂无分部数据
VRRM
| Government Solutions segment generated total | $105.3M | 47% |
| Commercial Services segment generated total | $97.8M | 44% |
| Parking Solutions segment generated total | $20.4M | 9% |